New Advances in Hybrid Closed-Loop Control of Insulin Therapy

Slides:

Advertisements

Similar presentations

Update on Artificial Pancreas Project

Advertisements

Progress Toward Artificial Pancreas (AP) Systems – A Timeline s 1980s : JDRF.

What's New in Basal Insulin for Diabetes

Jessica Kirk, MSN, RN, CPN, CDE Nurse Manager, Endo ECHO

Six Sensor CGM Array- Which do you trust?

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Clinical Trials in IBD.

Lifestyle and Professional CGM

Achieving Excellent Control of Hyperglycemia in Critical Care and Surgery, Safely: Continuous Glucose Monitoring: Does it Have a Future in the Hospital.

Special Consideration in Insulin Therapy

Program Goals. Inhaled Insulin: Overcoming Past Obstacles With Advances in Understanding.

Using the AGP to Standardize Glucose Reporting

SGLT2 Inhibitors: What Do the Data Mean for My Patients?

Updates on Emerging GLP-1 Receptor Agonists

Progression After Cancer Immunotherapy in Advanced NSCLC

Modern Strategies for Basal Insulin Use in T2D

Ask the Onychomycosis Expert, Part 2

What Comes Second?.

Insulin Innovation.

Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence.

Updates on Outcomes for Novel T2D Therapies

Hemoglobin A1c Targets for Glycemic Controls

Updates Abound.

Strategies for Assessing and Preserving Function in ALS

Best Practices in Advanced Glucose Monitoring

SGLT2 Inhibitors in the Modern Era: Why and Where?

Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.

Examining CV Effects of Basal Insulin Therapy

Updates to Managing Diabetes in the Long-Term Care Setting

Optimizing Patient Outcomes in IBD

Chronic Idiopathic Urticaria

How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?

Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma

GLP-1 Receptor Agonists: How Early Is Appropriate?

Statins and Glucose Metabolism: Are All Agents Alike?

Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?

Integrated Diabetes Care: How Can We Make the Best Use of New Technology?

A Journal Club on Lipid Management:

Gene Therapy: Past, Present, and Future

Insulin Innovation.

Immunotherapy for cSCC

Novel Approaches in T1D Management

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Predictive Low Glucose Suspend (PLGS)

Advancing Care Across the Spectrum of Pancreatic Cancer

The Primary Care Guide to New CGM Devices and the AGP

Novel Approaches to T1D Management

Antihyperglycemic Therapy

Advancing Patient Care in RA

Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.

Dual SGLT1/SGLT2 Inhibition in T1D

Hypoglycemia: The Most Common Barrier to Effective Diabetes Management

Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial

The Psychiatrist's Role in Tardive Dyskinesia

Improving Effective Basal Insulin Use in Clinical Practice

The Psychiatrist's Role in Tardive Dyskinesia

Deep Dive: Examining Emerging GLP-1 RAs From a Clinical Perspective

Getting PPG Under Control

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

Checkpoint Inhibitors in First-Line Advanced NSCLC

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors.

Statin Selection in Patients With Pre-Diabetes: Case Considerations

Practical Strategies for Overcoming Emotional Barriers to Insulin Initiation in the Primary Care Setting.

Practical Implementation and Optimization of A Closed Loop System

Fresh perspectives ON BASAL Insulins in diabetes care

Presentation transcript:

New Advances in Hybrid Closed-Loop Control of Insulin Therapy

The Increasing Importance of Time in Range

TIR Improves With CGM

CGM Helps People With T1D Reduce HbA1c, Hypoglycemia and Improve TIR

An Introduction to Automated Insulin Delivery (AID)

Medtronic MiniMed 670G System (FDA-Approved)

Real-World Use of MiniMed 670G

Tandem Control-IQ System (Emerging AID)

Evidence-Based Data on Control-IQ

New Data From iDCL Trial From ADA 2019

Application to Clinical Practice

Application to Clinical Practice

Abbreviations